The biotech giant that soared during Operation Warp Speed now faces regulatory hurdles, political scepticism, and dwindling ...

Presentation to Highlight Genprex's Study of Reqorsa® Gene Therapy in Combination with Tecentriq® for the Treatment of Exten ...

While India grapples with rising Covid cases and prepares for potential biological threats, the government's neglect of its ...

While the first dose had been administered to over a billion people, 93 percent of the population received a second dose ...

Dublin, May 23, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...

Parents throughout the country are putting their children's generosity, empathy and ethics to the test through the viral TikTok "cookie challenge." The challenge leaves one parent without a cookie ...

AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its lentiviral vector platform ... the fact that the viral capsids used ...

A phase 1 trial in the USA using a 1:1 mix of ChAd3-EBOV and ChAd3-SUDV in a 2 × 10 11 viral particle dose elicited responses ... Orthoebolavirus vaccine that consists of a single vector expressing ...

Myocardial infarction (MI) is a potential complication of COVID-19 vaccines. Most cases associated with MI were STEMIs linked to the Oxford-AstraZeneca ChAdOx1 viral-vector vaccine [11]. However, a ...

Mpox is a viral disease caused by the monkeypox ... “Chimpanzee adenovirus vector in the AstraZeneca COVID-19 vaccine does not cause monkeypox.” Reuters Fact Check. 8 Jun 2022.